APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. [electronic resource]
Producer: 20160218Description: e1794 p. digitalISSN:- 2041-4889
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cells, Cultured
- Cisplatin -- pharmacology
- Deoxycytidine -- analogs & derivatives
- Docetaxel
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Enzyme Activation -- drug effects
- Female
- Glutathione -- metabolism
- Humans
- Mice
- Mice, Nude
- Ovarian Neoplasms -- drug therapy
- Protein Folding -- drug effects
- Quinuclidines -- pharmacology
- Random Allocation
- Taxoids -- pharmacology
- Tumor Suppressor Protein p53 -- genetics
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.